Cancer Letters
Volume 203, Issue 2 , Pages 171-180 , January 2004

Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin–platinum(II) conjugates

  • Christian Lottner

      Affiliations

    • Institute of Inorganic Chemistry, University of Regensburg, Regensburg 93040, Germany
    • Institute of Pathology, University of Regensburg, Regensburg 93042, Germany
    • Corresponding Author InformationCorresponding author. Address: Institute of Pathology, University of Regensburg, Regensburg 93042, Germany. Tel.: +49-941-943-6640; fax: +49-941-943-6602
    • ,
  • Ruth Knuechel

      Affiliations

    • Institute of Pathology, University of Regensburg, Regensburg 93042, Germany
    • ,
  • Guenther Bernhardt

      Affiliations

    • Institute of Pharmacy, University of Regensburg, Regensburg 93040, Germany
    • ,
  • Henri Brunner

      Affiliations

    • Institute of Inorganic Chemistry, University of Regensburg, Regensburg 93040, Germany

Received 16 May 2003 ,Revised 8 September 2003 ,Accepted 8 September 2003.

References 

  1. Culine S. The present and future of combination chemotherapy in bladder cancer. Semin. Oncol. 2002;29:32–39
  2. Soulié P, Raymond E, Brienza S, Cvitkovic E. Oxaliplatin: the first DACH platinum in clinical practice. Bull. Cancer. 1997;84:665–673
  3. Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann. Oncol. 1998;9:1053–1071
  4. Cvitkovic E. Ongoing and unsaid on oxaliplatin: the hope. Br. J. Cancer. 1998;77:8–11
  5. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J. Natl Cancer Inst. 1998;90:889–905
  6. Sharman WM, Allen CM, van Lier JE. Photodynamic therapeutics: basic principles and clinical applications. Drug Discovery Today. 1999;4:507–517
  7. Lottner C, Bart K-C, Bernhardt G, Brunner H. Hematoporphyrin-derived soluble porphyrin–platinum conjugates with combined cytotoxic and phototoxic antitumor activity. J. Med. Chem. 2002;45:2064–2078
  8. O'Toole CM. In:  Webber MM,  Sikeley L editor. Human bladder cancer cell lines: HLA Class I and Class II antigen expression and susceptibility to cytostatic and cytolytic effects in vitro. In vitro models for cancer research. vol. IV:Boca Raton, FL, USA: CRC Press; 1986;p. 103–125
  9. Petzoldt JL, Leigh IM, Duffy PG, Sexton C, Masters JR. Immortalisation of human urothelial cells. Urol. Res. 1995;23:377–380
  10. Reile H, Birnböck H, Bernhardt G, Spruβ T, Schönenberger H. Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal. Biochem. 1990;187:262–267
  11. Bernhardt G, Reile H, Birnböck H, Spruβ T, Schönenberger H. Standardized kinetic microassay to quantitate differential chemosensitivity based on proliferative activity. J. Cancer Res. Clin. Oncol. 1992;118:35–43
  12. Spruβ T, Bernhardt G, Schickaneder E, Schönenberger H. Different response of murine and human mammary tumor models to a series of diastereoisomeric [1,2-bis(difluorophenyl)ethylenediamine]dichloroplatinum(II) complexes. J. Cancer Res. Clin. Oncol. 1991;117:435–443
  13. Bernhardt G, Koch M, Spruβ T, Gust R, Krauser R, Schlemmer R, et al. meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfatoplatinum(II)-pharmacokinetic studies. Arch. Pharm. Pharm. Med. Chem. 1999;332:195–200
  14. Karrer S, Szeimies R-M, Ebert A, Fickweiler S, Abels C, Bäumler W, et al. Dose-dependent photodynamic effects of 9-Acetoxy-2,7,12,17- tetrakis-(β-methoxyethyl)-porphycene in vitro. Lasers Med. Sci. 1997;12:307–312
  15. Hornung R, Fehr MK, Monti-Frayne J, Krasieva TB, Tromberg BJ, Berns MW, et al. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Photochem. Photobiol. 1999;70:624–629
  16. Rovers JP, Saarnak AE, de Jode M, Sterenborg HJ, Terpstra OT, Grahn MF. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Photochem. Photobiol. 2000;71:210–217

PII: S0304-3835(03)00593-7

doi: 10.1016/j.canlet.2003.09.001

Cancer Letters
Volume 203, Issue 2 , Pages 171-180 , January 2004

Article Tools

* Image Usage & Resolution